SABCS: Adding Camrelizumab to Neoadjuvant Chemo Beneficial in TNBC

FRIDAY, Dec. 13, 2024-- The addition of camrelizumab to neoadjuvant chemotherapy improves pathological complete response for patients with early or locally advanced triple-negative breast cancer, according to a study published online Dec. 13 in...